DCCT/EDIC研究中严重低血糖与缺血性心脏病的关联受基线微血管损伤程度影响
基于DCCT/EDIC队列1441例1型糖尿病患者随访约30年的数据,分析严重低血糖与缺血性心脏病的关联是否受基线微血管/大血管损伤替代指标影响。结果发现严重低血糖是缺血性心脏病的显著因素,且该关联随糖尿病病程、DCCT-ETDRS分级和DCSI评分增加而增强,但与心血管风险评分无显著交互作用。
要点
- 严重低血糖与缺血性心脏病风险显著相关,校正年龄和HbA1c后P=0.003
- 微血管损伤严重程度替代指标显著修饰严重低血糖与缺血性心脏病的关联
- 每增加1年糖尿病病程、1个DCCT-ETDRS单位或1个DCSI单位,风险比分别增加1.19、1.32、2.21倍
核心结论
- 在无基线大血管并发症的年轻1型糖尿病队列中,基线微血管损伤严重程度替代指标影响严重低血糖对缺血性心脏病的作用。
- 高龄伴高心血管风险评分本身并非严重低血糖与缺血性心脏病关联的必要条件,但该关联是多因素的。
研究设计与样本
- DCCT/EDIC研究志愿者1441例,糖尿病病程1-15年,随访约30年。
- 分析严重低血糖与缺血性心脏病(死亡、无症状/非致死性心肌梗死、血运重建或确诊心绞痛)的时间依赖性关联及交互作用。
主要发现
- 在仅校正年龄和HbA1c的模型中,严重低血糖是缺血性心脏病的显著因素(P=0.003)。
- 在完全校正模型中,严重低血糖仍是缺血性心脏病的显著因素(P<0.05)。
- 严重低血糖与微血管并发症严重程度替代指标的交互作用显著,但与心血管风险评分的交互作用不显著。
- 基于严重低血糖的缺血性心脏病风险比随糖尿病病程、DCCT-ETDRS单位和DCSI单位每增加1个单位分别增加1.19倍、1.32倍和2.21倍。
- 发生缺血性心脏病事件时,110例有严重低血糖的参与者中约15%心血管风险评分高。
关键数值与推荐
- 严重低血糖与缺血性心脏病关联的交互作用分析中,糖尿病病程、DCCT-ETDRS分级、DCSI评分和心血管风险评分作为基线微血管/大血管损伤严重程度的替代指标。
- 风险比增加幅度:每增加1年糖尿病病程为1.19倍,每增加1个DCCT-ETDRS单位为1.32倍,每增加1个DCSI单位为2.21倍。
临床怎么用
- 对1型糖尿病患者评估严重低血糖与缺血性心脏病风险时,应综合考虑基线微血管损伤严重程度(如视网膜病变分级、DCSI评分)和糖尿病病程。
- 年轻且无大血管并发症但存在微血管损伤的1型糖尿病患者,严重低血糖仍可能与缺血性心脏病风险相关,不应仅因年龄轻或心血管风险评分低而忽视。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Literature suggests that severe hypoglycemia (SH) may be linked to cardiovascular events only in older individuals with high cardiovascular risk score (CV-score). Whether a potential relationship between any-SH and cardiovascular disease exists and whether it is conditional on vascular damage severity in a young cohort with type 1 diabetes (T1D) without apparent macrovascular and no or mild-to-moderate microvascular complications at baseline is unknown. RESEARCH DESIGN AND METHODS: We evaluated data of 1,441 Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study volunteers (diabetes duration 1-15 years) followed for ∼30 years. Time-dependent associations between any-SH and ischemic heart disease (IHD: death, silent/nonfatal myocardial infarct, revascularization, or confirmed angina) and associations between interactions of any-SH with surrogates of baseline micro-/macrovascular damage severity and IHD were analyzed. Diabetes duration, steps on DCCT Early Treatment Diabetic Retinopathy Study severity scale (DCCT-ETDRS), Diabetes Complications Severity Index (DCSI), and CV-scores were considered as surrogates of baseline micro-/macrovascular damage severity. RESULTS: Without interactions, in the minimally adjusted model controlling for confounding bias by age and HbA1c, SH was a significant IHD factor (P = 0.003). SH remained a significant factor for IHD in fully adjusted models (P < 0.05). In models with interactions, interactions between SH and surrogates of microvascular complications severity, but not between SH and CV-score, were significant. Hazard ratios for IHD based on SH increased 1.19-fold, 1.32-fold, and 2.21-fold for each additional year of diabetes duration, DCCT-ETDRS unit, and DCSI unit, respectively. At time of IHD event, ∼15% of 110 participants with SH had high CV-scores. CONCLUSIONS: In a young cohort with T1D with no baseline macrovascular complications, surrogates of baseline microvascular damage severity impact the effect of SH on IHD. Older age with high CV-score per se is not mandatory for an association of SH with IHD. However, the association is multifactorial.
引用
- Fahrmann ER, Adkins L, Driscoll HK, et al. Modification of the Association Between Severe Hypoglycemia and Ischemic Heart Disease by Surrogates of Vascular Damage Severity in Type 1 Diabetes During ∼30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care. 2021. PMID: 34233927. doi:10.2337/dc20-2757
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。